We actively seek license-in opportunities to enrich our pipeline in our key therapeutic areas.

Under our code of conduct, “challenge, speed, investigation, smile”, we try speedy research and development in fields that other companies do not try. Through this approach, we have launched 1 or more items per year on average, which has contributed to increased pharmaceutical sales revenues over recent years.